Medical devices companies based on brand value worldwide 2026

Top ten medical device companies worldwide in 2026, by brand value

Medtronic is the most valuable medical device brand in the world in 2026, with a brand value of about 7.6 billion dollars. Fresenius follows closely on about 7.3 billion, then Siemens Healthineers on about 6.5 billion. Brand value is one of the less familiar but most revealing ways of ranking the medical device industry, measuring not how much a company sells but how much its name is worth, a reputation built over decades of trust with hospitals and patients. On the 2026 figures, Medtronic about 7.6 billion dollars leads Fresenius on about 7.3 billion, Siemens Healthineers on 6.5 billion, Philips on 5.8 billion and GE HealthCare on 5.2 billion, with the rest of the top ten between about 3 and 5 billion. A brand ranking offers a different and revealing angle on the medical device industry, one that rewards the trust and recognition a company has built rather than the raw scale of its sales, and the results reshuffle the familiar order of the giants.

Brand value measures the worth of the brand itself, not the size of the company, which is why the ranking differs from revenue league tables. The picture sits within our medtech R&D licensing and biggest companies by market value coverage.

Medtronic leads: Medtronic is the most valuable medical device brand in 2026 at about 7.6 billion dollars, narrowly ahead of Fresenius, with both up on 2025.

The top brands are split between the United States and Europe, with German brands Fresenius and Siemens Healthineers ranking highly, themes our medical devices revenue and medical technology industry coverage explores.

A note on the data. The figures show the top ten medical device companies worldwide in 2026 by brand value, based on Brand Finance style valuations. Brand value measures the brand, not revenue, and the 2026 figures are estimates and projections. Because brand valuation is a specialist discipline and different consultancies use different methods, the precise figures vary between sources, and the values here follow the Brand Finance approach, which estimates the financial worth of each brand. The ranking covers medical device and diagnostics companies, and brand value is estimated as the net economic benefit a company derives from owning its brand, following the royalty-relief method used by leading brand valuation consultancies.

Most Valuable Medical Device Brands

The table shows the top ten medical device companies by brand value in 2026. It shows Medtronic and Fresenius almost level at the top, followed by Siemens Healthineers, Philips and GE HealthCare, with the rest of the top ten closely bunched. Reading down the table shows how closely bunched the ranking is below the top two, with just over four billion dollars separating third place from tenth, a sign of how competitive the battle for brand value has become. Because brand values are modeled estimates and the 2026 figures for companies below the top two are projections, the ranking is best read as a consistent picture of the relative strength of the leading brands rather than a precise set of values. The change column is the most revealing part of the table, showing which brands are gaining ground and which are slipping, and hinting at the shifts in fortune that will shape next year ranking.

Which Medical Device Brand Is Most Valuable?

Medtronic is the most valuable medical device brand in 2026, at about 7.6 billion dollars, narrowly ahead of Fresenius on about 7.3 billion. The two have traded the top spot in recent years, with Fresenius briefly leading in 2024. The contest at the very top of the medical device brand ranking is one of the closest in the industry, with Medtronic and Fresenius separated by a margin so slim that the lead has changed hands more than once in recent years. Medtronic about 7.6 billion dollars edges Fresenius on about 7.3 billion, with Siemens Healthineers third on about 6.5 billion, and the top two together accounting for nearly a third of the brand value of the whole top ten. The battle for the title of most valuable medical device brand has become one of the most closely watched contests in healthcare, a genuine two-horse race in which the smallest shift in fortune can change the order at the very top.

The strength of the Medtronic brand reflects its scale, its breadth across cardiology, neuroscience and diabetes, and its long history as a leader in the industry, a standing our medtech industry data coverage frames.

Medtronic and Fresenius lead: Medtronic and Fresenius are almost level at the top of the ranking, ahead of Siemens Healthineers, Philips and GE HealthCare.

Fresenius stands out for the strength of its brand relative to its size, built on its global network of dialysis clinics and its central role in kidney care, which gives it a brand recognised by patients as well as by hospitals. The strength of the Fresenius brand, built on decades as the world leading provider of dialysis, shows how a focused company can build a brand every bit as valuable as those of far broader and larger rivals. The remarkable rise of Fresenius to the very top of the ranking, despite being far from the largest company by revenue, is the clearest illustration of how brand value can diverge sharply from sheer commercial scale.

How Is Brand Value Different From Revenue?

Brand value is not the same as revenue. It measures the financial worth of the brand itself, the premium a company earns from its reputation, separate from its factories, patents and products. That is why the brand ranking looks different from a revenue ranking. Understanding what brand value actually measures is essential to reading the ranking, since it captures something quite different from revenue or market capitalisation, namely the financial worth of the reputation attached to a company name. The concept of brand value can be slippery, but at its heart it is simple, the extra worth a company commands purely because of the reputation attached to its name, over and above the value of its products, patents and factories.

The distinction matters because some companies punch above their revenue weight in brand terms, while others with large revenues have comparatively modest brands, a nuance our medtech market by area coverage frames.

Fresenius punches high: Fresenius brand is worth a far larger share of its revenue than most rivals, reflecting the trust its name carries in dialysis.

Fresenius is the clearest example, with a brand worth a far larger share of its revenue than most rivals, reflecting the trust its name carries in dialysis and kidney care around the world. The gap between brand value and revenue is one of the most instructive things the ranking reveals, since it shows which companies have built reputations that outstrip their size and which have room to strengthen their brands. Looking across the ranking, the companies whose brands are worth the most relative to their revenue tend to be those with the strongest reputations among patients, not just hospitals, since consumer trust adds a premium that pure business-to-business brands lack.

Which Country Has the Most Valuable Brands?

The most valuable medical device brands are split between the United States and Europe. American brands hold about 63 percent of the brand value of the top ten, with German brands Fresenius and Siemens Healthineers on about 26 percent and Dutch Philips on about 11 percent. The geography of the most valuable medical device brands tells a familiar story of American dominance leavened by a handful of powerful European names, a pattern that mirrors the wider industry while giving Europe more prominence than revenue alone would. American brands about 63 percent of the top-ten brand value lead, ahead of German brands Fresenius and Siemens Healthineers on about 26 percent and Dutch Philips on about 11 percent, giving Europe a much larger share than in revenue terms. The national split of the most valuable brands is one of the more surprising features of the ranking, giving European names a prominence they do not enjoy in the revenue tables, a sign of the enduring strength of Europe medical technology heritage.

The American dominance reflects the depth of the United States medical device industry, though European brands punch above their weight, a pattern our global stock markets by country coverage frames.

US brands lead: American brands hold about 63 percent of the brand value of the top ten, with German brands on 26 percent and Dutch Philips on 11 percent.

The strength of the German and Dutch brands, Fresenius, Siemens Healthineers and Philips, reflects Europe long history in medical technology, especially in imaging, dialysis and hospital equipment. The prominence of European brands in a ranking otherwise dominated by American companies is a reminder that medical technology has deep roots on both sides of the Atlantic, with Europe especially strong in imaging and hospital equipment. The strength of the German and Dutch brands is a reminder that the history of medical technology is as much European as American, with roots in the imaging, dialysis and hospital-equipment industries that grew up on the continent.

Which Brands Are Growing Fastest?

Brand values are rising across most of the top ten. Boston Scientific, Stryker and Abbott have seen the fastest brand-value growth, each up more than 6 percent, while Medtronic and Siemens Healthineers have grown more modestly. The movement in brand values from year to year is a useful barometer of which companies are winning the battle for reputation, and the fastest risers are often those gaining ground in the highest-growth and most visible areas of medicine. Boston Scientific about 8.8 percent, Stryker on about 7 percent and Abbott on about 6.4 percent have grown their brand values fastest, while Medtronic on about 2.7 percent and Fresenius, flat on the year, have grown more slowly. The pace at which individual brands gain or lose value is one of the clearest signals of momentum in the industry, and the fastest risers are usually the companies making the boldest moves in the most visible corners of medicine.

The rising brand values reflect a growing and profitable industry, in which strong brands command a premium with hospitals and patients alike, a strength our medtech M&A coverage frames through the deals reshaping it.

Boston Scientific fastest: Boston Scientific, Stryker and Abbott have grown their brand values fastest, each up more than 6 percent on the year.

The fastest-growing brands are those gaining share in high-growth areas such as cardiology and surgical robotics, where a strong brand helps win the trust of surgeons and hospitals making high-stakes purchasing decisions. The link between brand-value growth and success in high-growth areas is clear, since a strong and rising brand both reflects and reinforces a company momentum, helping it win the trust of the surgeons and hospitals it sells to. The clustering of the fastest-growing brands in cardiology and surgical robotics is no coincidence, since these are the areas where a trusted brand most influences the high-stakes decisions of surgeons and hospital buyers.

Brand Value and Brand Strength

Brand strength, a measure of how powerful a brand is separate from its financial value, is led by Abbott and Siemens Healthineers, reflecting their strong reputations with both healthcare professionals and, in Abbott case, consumers. Brand strength, distinct from brand value, measures the raw power of a brand, and the leaders on this measure reveal which companies command the deepest trust among the doctors, hospitals and patients who ultimately choose their products. The distinction between brand strength and brand value is one of the more subtle but important ideas in brand analysis, separating the raw power and appeal of a brand from the financial worth that its size confers upon it.

The strength of the Abbott brand reflects its reach into consumer health through products such as its continuous glucose monitors, which have made it a household name, a reach our in vitro diagnostics coverage frames.

Abbott leads: Abbott and Siemens Healthineers lead on brand strength, a measure of how powerful a brand is separate from its financial value.

Brand strength and brand value do not always align, and some companies with very strong brands rank lower by value simply because they are smaller, while larger companies can carry substantial brand value even with a less dominant reputation. The divergence between brand strength and brand value is one of the subtler features of the ranking, and it explains why a smaller company with a fiercely loyal following can outrank a larger rival on strength while trailing it on value. The way brand strength and brand value can diverge is one of the most instructive lessons of the ranking, showing that a fiercely loved brand and a financially valuable one are related but far from identical things.

Medtronic vs Fresenius

Medtronic and Fresenius have contested the top of the medical device brand ranking for years. Medtronic led for three years, Fresenius took the top spot in 2024, and Medtronic regained it in 2025 and holds it in 2026. The rivalry between Medtronic and Fresenius for the title of most valuable medical device brand is one of the defining contests in the industry, pitting a broad devices giant against a focused leader in kidney care. The Medtronic and Fresenius rivalry captures in miniature the whole story of brand value in medical technology, a contest between breadth and focus, scale and specialisation, that has produced one of the closest races in the industry. The two companies could hardly be more different in shape, Medtronic a sprawling giant spanning cardiology, neuroscience and diabetes, Fresenius a focused specialist built around dialysis and kidney care, and yet in brand terms they stand almost exactly level.

The closeness of the contest reflects how evenly matched the two brands are, despite their very different businesses, one broad across devices and the other focused on dialysis, a rivalry our medtech market worldwide coverage frames.

A close contest: Medtronic and Fresenius have traded the top spot for years, with Fresenius briefly leading in 2024 before Medtronic regained it.

The see-saw at the top is driven by shifts in each company fortunes and by divestitures, with Medtronic reshaping its portfolio and Fresenius sharpening its focus on kidney care, each affecting the value of its brand. The frequent changes at the top, driven by divestitures and shifts in strategy, keep the rivalry between Medtronic and Fresenius alive, and make the medical device brand ranking one of the most closely watched in healthcare. Looking ahead, the contest between Medtronic and Fresenius seems likely to remain close, with each capable of retaking the lead depending on how successfully it reshapes its business and strengthens its brand.

The Rising Value of Medtech Brands

The total brand value of the leading medical device companies has grown steadily, from about 38 billion dollars for the top brands in 2020 to about 54 billion in 2026, reflecting the growth and rising profitability of the industry. The steady growth in the total brand value of the leading medical device companies is a quiet but telling measure of the health of the industry, reflecting both its expansion and the rising premium that strong brands command. The total brand value of the leading medical device companies rose from about 38 billion dollars in 2020 to about 44 billion in 2022, about 48 billion in 2024 and about 54 billion in 2026, tracking the growth of the industry. The rising tide of medical device brand value lifts almost all the leading companies, and its steady climb is a quiet but reliable indicator of an industry growing more profitable and its leading names more trusted.

The steady growth in sector brand value tracks the expansion of the medical device market itself, a link our medtech market by segment coverage frames through the revenue behind the brands.

A steady rise: the total brand value of the leading medical device companies has grown from about 38 billion dollars in 2020 to about 54 billion in 2026.

Concentrated at the top: the top three brands account for about 40 percent of the brand value of the entire top ten.

As the industry grows and consolidates, brand value is increasingly concentrated among the largest players, whose scale and reach let them build brands that smaller rivals struggle to match. The concentration of brand value among the largest companies is a natural consequence of the scale required to build a global medical device brand, and it leaves smaller specialists struggling to match the reach of the giants. The growing concentration of brand value at the top is a natural feature of a maturing industry, where the scale needed to build a truly global brand increasingly favours the largest and most established companies.

How AI Is Reshaping Brands

Artificial intelligence is beginning to reshape medical device brands, as companies that embed AI in their products are seen as more innovative and command a brand premium, especially in imaging and diagnostics. Artificial intelligence is emerging as a new driver of medical device brand value, rewarding the companies seen as most innovative and reshaping how hospitals and patients judge the reputation of the leading names. The arrival of artificial intelligence as a driver of brand value marks a new chapter in the industry, rewarding the companies that can convince hospitals and patients they are at the cutting edge of intelligent, connected medicine. As algorithms move from the laboratory into everyday clinical practice, the brands most closely associated with trustworthy, well-regulated artificial intelligence are likely to enjoy a growing advantage in the eyes of cautious hospital buyers.

The brands investing most heavily in AI, from Siemens Healthineers to GE HealthCare, are using it to strengthen their reputations for innovation, a shift our AI market size coverage frames.

Broad-based growth: between 2024 and 2026 most of the leading brands grew in value, with Fresenius the main exception after its 2024 peak.

The link between AI and brand value is expected to strengthen, as the ability to offer intelligent, connected devices becomes central to how hospitals and patients judge the leading medical technology brands. The growing link between artificial intelligence and brand value points to the future of the ranking, in which the companies seen as leaders in intelligent, connected devices are likely to command an ever-larger brand premium.

Medical Device Brands in Numbers

A few numbers capture the ranking. Medtronic is the most valuable medical device brand in 2026 at about 7.6 billion dollars, Fresenius follows on about 7.3 billion, and American brands hold about 63 percent of the brand value of the top ten. These figures together map a ranking that rewards reputation as much as scale, led by two closely matched giants and rising steadily as the industry grows and its leading brands become ever more valuable. The ranking as a whole tells a story of an industry where reputation carries real financial weight, led by two closely matched giants and rising steadily as its leading brands grow ever more valuable. The headline numbers, Medtronic at about 7.6 billion dollars and Fresenius at about 7.3 billion, capture a contest so close that the ranking could plausibly change again with the next set of results.

The figures matter because a strong brand commands a premium with hospitals and patients, and brand value is a measure of reputation that revenue alone cannot capture, a link our medical technology market coverage explores.

Together these figures show a ranking led by Medtronic and Fresenius, split between American and European brands, and rising steadily as the industry grows and brands become ever more valuable. For now, the medical device brand ranking stands as a reminder that in healthcare, as in any industry, reputation carries a real and measurable financial value, one that the largest companies guard and grow with care.

Medical Device Brands: The Big Picture

Taken together, the most valuable medical device brands of 2026 map an industry led by Medtronic and Fresenius, split between the United States and Europe, a story our global pharmaceutical industry coverage sets in the wider healthcare context.

Whether Medtronic holds off Fresenius will depend on how each reshapes its business, but for now the two stand clear at the top of a ranking that rewards reputation as much as revenue, alongside the listed companies in our Nasdaq stock market overview.

Frequently Asked Questions: Medical Device Brands